iLite® Functional Bioassays
The iLite® Functional Bioassay portfolio consists of cell lines provided in an “assay-ready” format for a rapid and convenient workflow. The assay-ready format also reduces assay variability, optimizing its use in screening, characterization, stability, and potency studies. iLite cell lines can be tailored to virtually any biopharmaceutical target.
Receive your quote directly from the manufacturer.
The iLite Functional Bioassay portfolio is based on a reporter gene system and offers a convenient and powerful way of measuring and quantifying drug potency, detecting neutralizing antibodies (NAbs), and assessing immunogenicity.
The portfolio consists of:
Complement Products
iLite® C5a [BM4075]
Cytokine responsive
iLite® RANKL [BM4052]
iLite® TNF-alpha [BM3044]
iLite® Type I IFN [BM3049]
Hormone responsive
iLite® hCG [BM4080]
iLite® Insulin [BM3060]
Interleukine responsive
iLite® IL-2 [BM4002]
iLite® IL-6 [BM4061]
iLite® IL-12 [BM4012]
iLite® IL-23 [BM4023]
Growth Factors
iLite® VEGF [BM4021]
iLite® FGF-21 [BM3071]
iLite® GM-CSF [BM4050]
iLite® G-CSF [BM4055]
Toll-Like Receptors
iLite® TLR4 [BM4025]
iLite® TLR9 [BM6069]
